Obesity: open trials in United Kingdom

84 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT07919405
A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
West Walk Surgery, Bristol · Attenborough Surgery, Bushey · Addenbrooke's Hospital Cambridge, Cambridge · Hathaway Medical Centre, Chippenham · Belmont Health Centre, Harrow · HMC Health - Heston - The Meadows Centre for Health, Hounslow · Healthcare Central London - South Westminster Centre for Health, London · William Harvey Research Institute, London · Newquay Health Centre, Newquay · Trinity Surgery, Wisbech
Registry updated 2026-11-05
NCT06672549
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Trial Treatment · Phase 3 · Eli Lilly and Company
Barnsley Hospital NHS Foundation Trust, Barnsley · Bristol Royal Hospital for Children, Bristol · Addenbrookes Hospital, Cambridge · Ninewells Hospital, Dundee · Northwick Park Hospital, Harrow · Hull Royal Infirmary - MAIN, Hull · Alder Hey Children's Hospital, Liverpool
Registry updated 2026-11-04
NCT06672939
A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities
Trial Treatment · Phase 3 · Eli Lilly and Company
Barnsley Hospital NHS Foundation Trust, Barnsley · Ninewells Hospital, Dundee · Hull Royal Infirmary, Hull
Registry updated 2026-11-04
NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Trial Treatment · Phase 2 · Eli Lilly and Company
FutureMeds - Birmingham, Birmingham · Layton Medical Centre, Blackpool · Southmead Hospital, Bristol · FutureMeds - Liverpool, Bromborough · Futuremeds-Newcastle, Newcastle · Newquay Health Centre, Newquay · George Eliot Hospital, Nuneaton · The Adam Practice, Poole · Clifton Medical Centre, Rotherham · Rame Group Practice, Torpoint
Registry updated 2026-11-04
NCT06937086
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Trial Treatment · Phase 3 · Eli Lilly and Company
Southmead Hospital, Bristol · Ninewells Hospital and Medical School, Dundee · Royal Devon & Exeter Hospital, Exeter · Royal London Hospital, London
Registry updated 2026-11-04
NCT07062094
Safety and Effectiveness of Orbera365™ Intragastric Balloon System
Research · Boston Scientific Corporation
UHCW NHS Trust, Coventry
Registry updated 2026-11-04
NCT07353931
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Trial Treatment · Phase 3 · Eli Lilly and Company
Velocity Clinical Research, Bristol, Bristol · FutureMeds Glasgow - CPS Research, Glasgow · FutureMeds - London, London · Futuremeds-Newcastle, Newcastle · Atlantic Medical, Penzance · Woodstock Bower Surgery, Rotherham · Panthera Biopartners - Sheffield, Sheffield · Panthera Clinic - York, York
Registry updated 2026-11-04
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Layton Medical Centre, Blackpool · Ashton Medical Group - Chapel House, Lancashire · St Pancras Clinical Research, London · Atlantic Medical, Penzance · Abbeywell Surgery, Romsey · Marine Lake Medical Practice, West Kirby
Registry updated 2026-11-03
NCT07911514
A Trial to Assess the Relative Bioavailability of Different Subcutaneous Formulations of AZD9550 and AZD6234
Trial Treatment · Phase 1 · AstraZeneca
Ruddington
Registry updated 2026-11-02
NCT07850050
SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight
Trial Treatment · Phase 3 · Boehringer Ingelheim
Glasgow Royal Infirmary, Glasgow · Leicester General Hospital, Leicester
Registry updated 2026-10-30
NCT07850063
ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Bradford Royal Infirmary, Bradford · St James's University Hospital, Leeds · Leicester Royal Infirmary, Leicester · St. Bartholomew's Hospital, London · Guy's Hospital, London · Derriford Hospital, Plymouth
Registry updated 2026-10-30
NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Trial Treatment · Phase 3 · Amgen
University Hospital Monklands, Airdrie · North Tyneside General Hospital, Ashington · Ormeau Clinical Trials Ltd, Belfast · Royal Bournemouth Hospital, Bournemouth · Princess of Wales Hospital, Bridgend · Southmead Hospital, Bristol · St Richards Hospital, Chichester · Ninewells Hospital and Medicine School, Dundee · Royal Devon and Exeter Hospital, Exeter · Glasgow Royal Infirmary, Glasgow · Monkfield Medical Practice, Great Cambourne · Wycombe Hospital, High Wycombe · Highlands Clinical Research Facility, Raigmore Hospital, Inverness · University Hospital Crosshouse, Kilmarnock · Glenfield Hospital, Leicester · Kings College Hospital, London · University College London Hospital, London · St Georges Hospital, London · Manchester Royal Infirmary, Manchester · Newcastle NIHR Commercial Research Delivery Centre, Newcastle upon Tyne · Craigavon Area Hospital, Portadown, Craigavon · Ashfields Primary Care Centre, Sandbach · University Hospital of North Tees, Stockton-on-Tees · Breckland Alliance Research, Thetford · Pinderfields Hospital, Wakefield · Marine Lake & Estuary Medical Practice, West Kirby
Registry updated 2026-10-29
NCT07784270
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Trial Treatment · Phase 3 · AstraZeneca
Chippenham · Corby · Dunfermline · Hull · Northwood
Registry updated 2026-10-28
NCT06842186
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
Trial Treatment · Phase 1/2 · Wave Life Sciences USA, Inc.
Parexel International Early Phase Clinical Unit, Harrow · Simbec-Orion Clinical Pharmacology, Merthyr Tydfil
Registry updated 2026-10-26
NCT07283978
Real-world Exploration of Digital iNnovation in the Management of Excess Weight
Trial Treatment · Guy's and St Thomas' NHS Foundation Trust
Guy' & St Thomas' NHS Foundation Trust, London
Registry updated 2026-10-23
NCT07789106
A Study on Ubiquinol on Fatigue and Muscle Strength in Healthy Adults Taking GLP-1 Agonists
Trial Treatment · StudySetGo
Office 1110 3 Fitzroy Place, 1/1, Sauchiehall Street, Glasgow
Registry updated 2026-10-19
NCT07351045
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Monklands Hospital, Airdrie · Birmingham Heartlands Hospital, Birmingham · Rowden Surgery, Chippenham · Queen Elizabeth University Hospital Glasgow, Glasgow · Leicester General Hospital, Leicester · Hammersmith Hospital, London · Royal Victoria Infirmary, Newcastle upon Tyne · Soham Staploe Medical Centre, Soham · Singleton Hospital, Swansea
Registry updated 2026-10-13
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
Aberdeen Royal Infirmary, Aberdeen · Antrim Area Hospital, Antrim · Fylde Coast Clinical Research at Layton Medical Centre, Blackpool · Southmead General Hospital, Bristol · Ninewells Hospital and Medical School - Tayside Health Board, Dundee · HMC Health Group, Hounslow · Hull Royal Infirmary, Hull · George Eliot Hospital, Nuneaton · Knowle House Surgery, Plymouth · Musgrove Park Hospital, Taunton
Registry updated 2026-10-13
NCT07511205
A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.
Trial Treatment · Phase 1 · AstraZeneca
Harrow
Registry updated 2026-10-13
NCT07667803
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
Trial Treatment · Phase 3 · AstraZeneca
Ashton-under-Lyne · Blackpool · Chesterfield · Corby · Ely · Glasgow · Hounslow · Leicester · Metropolitan Borough of Wirral · Nantwich · Poole · Rotherham · Stowmarket · Wansford · Witney · Yate
Registry updated 2026-10-13
NCT07861100
A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular Disease and Either Overweight or Obesity
Trial Treatment · Phase 3 · Novo Nordisk A/S
Aberdeen Royal Infirmary - Diabetes, Aberdeen · Ashton Medical Group, Ashton-under-Lyne · The Health Centre, Bradford on Avon · Royal Sussex County Hospital, Brighton · Southmead Hospital - Cardiology Research, Bristol · West Walk Surgery, Bristol · St. Richard's Hospital_Cardiology, Chichester · University Hospital Coventry - WISDEM Centre, Coventry · Ninewells Hospital, Dundee · Queen Elizabeth University Hospital, Glasgow · Northwick Park Hospital - Cardiac Research Dept, Harrow · Leicester General Hospital - Leicester Diabetes Centre, Leicester · Aintree University Hospital, Liverpool · The Royal London Hospital, London · Royal Victoria Infirmary, Newcastle upon Tyne · Newquay Health Centre, Newquay · Penicuik Medical Practice, Penicuik · The Adam Practice, Poole · Staploe Medical Centre, Soham · Moorgreen Hospital, Southampton · Breckland Alliance, Thetford · Sandwell Health Campus, West Bromwich · Marine Lake Medical Practice, West Kirby
Registry updated 2026-10-06
NCT07684144
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Trial Treatment · Phase 3 · Amgen
FutureMeds - Birmingham, Birmingham
Registry updated 2026-10-05
NCT07253285
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Trial Treatment · Phase 3 · Novo Nordisk A/S
Birmingham Children's Hospital, Birmingham · Alder Hey Children's Hospital, Liverpool · University College Hospital - Paediatric Services, London
Registry updated 2026-09-30
NCT07776509
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
Airdrie · Chippenham · Hull · Llandough · Rotherham
Registry updated 2026-09-25
NCT06439277
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Trial Treatment · Phase 3 · Eli Lilly and Company
Addenbrooke's Hospital, Cambridge · Royal Hospital for Children, Glagow · Leeds General Infirmary, Leeds · Leicester Royal Infirmary, Leicester · Alder Hey Children's Hospital, Liverpool · Paediatric and Adolescent OutpatientsElizabeth Garrett Anderson WingUniversity College Hospital, London · Royal Victoria Infirmary, Newcastle upon Tyne · Sheffield Children's Hospital, Sheffield · Southampton General Hospital, Southampton
Registry updated 2026-09-24

All Obesity trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error